STRIDES, NCT05490563: - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia |
|
|
| Terminated | 2/3 | 23 | Europe, US, RoW | SLS-005, Placebo | Seelos Therapeutics, Inc. | Spinocerebellar Ataxia Type 3 | 11/23 | 11/23 | | |
| Active, not recruiting | N/A | 200 | US | | The Methodist Hospital Research Institute, University of Michigan, University of Minnesota, University of Utah, University of California, Los Angeles, University of Chicago, University of South Florida, Harvard University, Johns Hopkins University, University of Florida, Columbia University, Emory University, University of California, San Francisco, University of Alabama at Birmingham, University of Colorado, Denver, University of Rochester, Stanford University, Northwestern University, German Center for Neurodegenerative Diseases (DZNE), Institut de Recherche sur la Moelle épinière et l'Encéphale, University of Pennsylvania, Ohio State University, University of Iowa | Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia 3 | 12/23 | 12/23 | | |
| Recruiting | N/A | 2000 | Canada, US, RoW | | Friedreich's Ataxia Research Alliance, Children's Hospital of Philadelphia, University of Rochester | Friedreich Ataxia, Neuro-Degenerative Disease | 01/30 | 01/30 | | |
